[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global and United States Becker Muscular Dystrophy Drug In-Depth Research Report 2017-2022

November 2017 | 101 pages | ID: G8A230EB3D1EN
US Market Insights (UMI)

US$ 3,190.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Becker Muscular Dystrophy Drug industry.

Major Companies

Italfarmaco SpA
Milo Biotechnology LLC
PTC Therapeutics Inc
ReveraGen BioPharma Inc
Sarepta Therapeutics Inc
...

Key Regions

North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main types of products

Becker Muscular Dystrophy Drug Market, byvinostat
Becker Muscular Dystrophy Drug Market, byaluren
Becker Muscular Dystrophy Drug Market, byicatechin
Becker Muscular Dystrophy Drug Market, byM-210
Becker Muscular Dystrophy Drug Market, byhers

Becker Muscular Dystrophy Drug Market, by Key Consumers

Hospital
Clinic
Others

CHAPTER ONE GLOBAL BECKER MUSCULAR DYSTROPHY DRUG MARKET OVERVIEW

1.1 Global Becker Muscular Dystrophy Drug Market Sales Volume Revenue and Price 2012-2017
1.2 Becker Muscular Dystrophy Drug, by inostat 2012-2017
  1.2.1 Global Becker Muscular Dystrophy Drug Sales Market Share by inostat 2012-2017
  1.2.2 Global Becker Muscular Dystrophy Drug Revenue Market Share by inostat 2012-2017
  1.2.3 Global Becker Muscular Dystrophy Drug Price by inostat 2012-2017
  1.2.4
  1.2.5
1.3 Becker Muscular Dystrophy Drug, by luren 2012-2017
  1.3.1 Global Becker Muscular Dystrophy Drug Sales Market Share by luren 2012-2017
  1.3.2 Global Becker Muscular Dystrophy Drug Revenue Market Share by luren 2012-2017
  1.3.3 Global Becker Muscular Dystrophy Drug Price by luren 2012-2017
  1.3.4
  1.3.5
1.4 Becker Muscular Dystrophy Drug, by catechin 2012-2017
  1.4.1 Global Becker Muscular Dystrophy Drug Sales Market Share by catechin 2012-2017
  1.4.2 Global Becker Muscular Dystrophy Drug Revenue Market Share by catechin 2012-2017
  1.4.3 Global Becker Muscular Dystrophy Drug Price by catechin 2012-2017
  1.4.4
  1.4.5
1.5 Becker Muscular Dystrophy Drug, by -210 2012-2017
  1.5.1 Global Becker Muscular Dystrophy Drug Sales Market Share by -210 2012-2017
  1.5.2 Global Becker Muscular Dystrophy Drug Revenue Market Share by -210 2012-2017
  1.5.3 Global Becker Muscular Dystrophy Drug Price by -210 2012-2017
  1.5.4
  1.5.5
1.6 Becker Muscular Dystrophy Drug, by ers 2012-2017
  1.6.1 Global Becker Muscular Dystrophy Drug Sales Market Share by ers 2012-2017
  1.6.2 Global Becker Muscular Dystrophy Drug Revenue Market Share by ers 2012-2017
  1.6.3 Global Becker Muscular Dystrophy Drug Price by ers 2012-2017
  1.6.4
  1.6.5

CHAPTER TWO UNITED STATES BECKER MUSCULAR DYSTROPHY DRUG MARKET OVERVIEW

2.1 United States Becker Muscular Dystrophy Drug Market Sales Volume Revenue and Price 2012-2017
2.2 Becker Muscular Dystrophy Drug, by inostat 2012-2017
  2.2.1 United States Becker Muscular Dystrophy Drug Sales Market Share by inostat 2012-2017
  2.2.2 United States Becker Muscular Dystrophy Drug Revenue Market Share by inostat 2012-2017
  2.2.3 United States Becker Muscular Dystrophy Drug Price by inostat 2012-2017
  2.2.4
  2.2.5
2.3 Becker Muscular Dystrophy Drug, by luren 2012-2017
  2.3.1 United States Becker Muscular Dystrophy Drug Sales Market Share by luren 2012-2017
  2.3.2 United States Becker Muscular Dystrophy Drug Revenue Market Share by luren 2012-2017
  2.3.3 United States Becker Muscular Dystrophy Drug Price by luren 2012-2017
  2.3.4
  2.3.5
2.4 Becker Muscular Dystrophy Drug, by catechin 2012-2017
  2.4.1 United States Becker Muscular Dystrophy Drug Sales Market Share by catechin 2012-2017
  2.4.2 United States Becker Muscular Dystrophy Drug Revenue Market Share by catechin 2012-2017
  2.4.3 United States Becker Muscular Dystrophy Drug Price by catechin 2012-2017
  2.4.4
  2.4.5
2.5 Becker Muscular Dystrophy Drug, by -210 2012-2017
  2.5.1 United States Becker Muscular Dystrophy Drug Sales Market Share by -210 2012-2017
  2.5.2 United States Becker Muscular Dystrophy Drug Revenue Market Share by -210 2012-2017
  2.5.3 United States Becker Muscular Dystrophy Drug Price by -210 2012-2017
  2.5.4
  2.5.5
2.6 Becker Muscular Dystrophy Drug, by ers 2012-2017
  2.6.1 United States Becker Muscular Dystrophy Drug Sales Market Share by ers 2012-2017
  2.6.2 United States Becker Muscular Dystrophy Drug Revenue Market Share by ers 2012-2017
  2.6.3 United States Becker Muscular Dystrophy Drug Price by ers 2012-2017
  2.6.4
  2.6.5

CHAPTER THREE BECKER MUSCULAR DYSTROPHY DRUG BY REGIONS 2012-2017

3.1 Global Becker Muscular Dystrophy Drug Sales Market Share by Regions 2012-2017
3.2 Global Becker Muscular Dystrophy Drug Revenue Market Share by Regions 2012-2017
3.3 Global Becker Muscular Dystrophy Drug Price by Regions 2012-2017
3.4 North America
  3.4.1 United States
    3.4.1.1 California
    3.4.1.2 Texas
    3.4.1.3 New York
    3.4.1.4 Others in United States
  3.4.2 Canada
3.5 Latin America
  3.5.1 Mexico
  3.5.2 Brazil
  3.5.3 Argentina
  3.5.4 Others in Latin America
3.6 Europe
  3.6.1 Germany
  3.6.2 United Kingdom
  3.6.3 France
  3.6.4 Italy
  3.6.5 Spain
  3.6.6 Russia
  3.6.7 Netherland
  3.6.8 Others in Europe
3.7 Asia & Pacific
  3.7.1 China
  3.7.2 Japan
  3.7.3 India
  3.7.4 Korea
  3.7.5 Australia
  3.7.6 Southeast Asia
    3.7.6.1 Indonesia
    3.7.6.2 Thailand
    3.7.6.3 Philippines
    3.7.6.4 Vietnam
    3.7.6.5 Singapore
    3.7.6.6 Malaysia
    3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
  3.8.1 South Africa
  3.8.2 Egypt
  3.8.3 Turkey
  3.8.4 Saudi Arabia
  3.8.5 Iran
  3.8.6 Others in Africa & Middle East

CHAPTER FOUR GLOBAL BECKER MUSCULAR DYSTROPHY DRUG BY COMPANIES 2012-2017

4.1 Global Becker Muscular Dystrophy Drug Sales Volume Market Share by Companies 2012-2017
4.2 Global Becker Muscular Dystrophy Drug Revenue Share by Companies 2012-2017
4.3 Global Top Companies Becker Muscular Dystrophy Drug Key Product Model and Market Performance
4.4 Global Top Companies Becker Muscular Dystrophy Drug Key Target Consumers and Market Performance

CHAPTER FIVE UNITED STATES BECKER MUSCULAR DYSTROPHY DRUG BY COMPANIES 2012-2017

5.1 United States Becker Muscular Dystrophy Drug Sales Volume Market Share by Companies 2012-2017
5.2 United States Becker Muscular Dystrophy Drug Revenue Share by Companies 2012-2017
5.3 United States Top Companies Becker Muscular Dystrophy Drug Key Product Model and Market Performance
5.4 United States Top Companies Becker Muscular Dystrophy Drug Key Target Consumers and Market Performance

CHAPTER SIX GLOBAL BECKER MUSCULAR DYSTROPHY DRUG BY CONSUMER 2012-2017

6.1 Global Becker Muscular Dystrophy Drug Sales Market Share by Consumer 2012-2017
6.2 Hospital
6.3 Clinic
6.4 Others
6.5 Consuming Habit and Preference

CHAPTER SEVEN GLOBAL BECKER MUSCULAR DYSTROPHY DRUG BY CONSUMER 2012-2017

7.1 Global Becker Muscular Dystrophy Drug Sales Market Share by Consumer 2012-2017
7.2 Hospital
7.3 Clinic
7.4 Others
7.5 Consuming Habit and Preference

CHAPTER EIGHT TOP COMPANIES PROFILE

8.1 Italfarmaco SpA
  8.1.1 Italfarmaco SpA Company Details and Competitors
  8.1.2 Italfarmaco SpA Key Becker Muscular Dystrophy Drug Models and Performance
  8.1.3 Italfarmaco SpA Becker Muscular Dystrophy Drug Business SWOT Analysis and Forecast
  8.1.4 Italfarmaco SpA Becker Muscular Dystrophy Drug Sales Volume Revenue Price Cost and Gross Margin
8.2 Milo Biotechnology LLC
  8.2.1 Milo Biotechnology LLC Company Details and Competitors
  8.2.2 Milo Biotechnology LLC Key Becker Muscular Dystrophy Drug Models and Performance
  8.2.3 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Business SWOT Analysis and Forecast
  8.2.4 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Sales Volume Revenue Price Cost and Gross Margin
8.3 PTC Therapeutics Inc
  8.3.1 PTC Therapeutics Inc Company Details and Competitors
  8.3.2 PTC Therapeutics Inc Key Becker Muscular Dystrophy Drug Models and Performance
  8.3.3 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Business SWOT Analysis and Forecast
  8.3.4 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Sales Volume Revenue Price Cost and Gross Margin
8.4 ReveraGen BioPharma Inc
  8.4.1 ReveraGen BioPharma Inc Company Details and Competitors
  8.4.2 ReveraGen BioPharma Inc Key Becker Muscular Dystrophy Drug Models and Performance
  8.4.3 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Business SWOT Analysis and Forecast
  8.4.4 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Sales Volume Revenue Price Cost and Gross Margin
8.5 Sarepta Therapeutics Inc
  8.5.1 Sarepta Therapeutics Inc Company Details and Competitors
  8.5.2 Sarepta Therapeutics Inc Key Becker Muscular Dystrophy Drug Models and Performance
  8.5.3 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Business SWOT Analysis and Forecast
  8.5.4 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Sales Volume Revenue Price Cost and Gross Margin

...

CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN

9.1 Becker Muscular Dystrophy Drug Industry Chain Structure
  9.1.1 R&D
  9.1.2 Raw Materials (Components)
  9.1.3 Manufacturing Plants
  9.1.4 Regional Trading (Import Export and Local Sales)
  9.1.5 Online Sales Channel
  9.1.6 Offline Channel
  9.1.7 End Users
9.2 Becker Muscular Dystrophy Drug Manufacturing
  9.2.1 Key Components
  9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

CHAPTER TEN GLOBAL BECKER MUSCULAR DYSTROPHY DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Becker Muscular Dystrophy Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by inostat (2017-2022)
10.5 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by luren (2017-2022)
10.6 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by catechin (2017-2022)
10.7 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by -210 (2017-2022)
10.8 Global Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by ers (2017-2022)

CHAPTER ELEVEN UNITED STATES BECKER MUSCULAR DYSTROPHY DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 United States Becker Muscular Dystrophy Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by inostat (2017-2022)
11.5 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by luren (2017-2022)
11.6 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by catechin (2017-2022)
11.7 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by -210 (2017-2022)
11.8 United States Becker Muscular Dystrophy Drug Sales (K Pcs) Forecast by ers (2017-2022)

CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION

12.1 Development Trend
12.2 Research Conclusion

CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES

Table Global Becker Muscular Dystrophy Drug Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Becker Muscular Dystrophy Drug Revenue (Million USD) and Growth

More Publications

Need Help?

Ask a Question

Market Reports

All Categories